29 reports

Viral Vector and Plasmid DNA: Technologies and Global Markets Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials Chapter ## Summary and Highlights Chapter ## Market and Techn

  • Gene Therapy
  • Medical Biotechnology
  • World

TUBERCULOSIS ##. ##. ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Vaccine
  • World
  • Market Size

In addition, according to Avert Organization (U. K. ), in 2016, approximately ##. ## million people were found to be suffering from human immunodeficiency virus (HIV), and ## million people died due to HIV-related diseases in 2016.

  • Gene Therapy
  • Medical Biotechnology
  • Vaccine
  • World
  • Market Size

TUBERCULOSIS ##. ##. ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Vaccine
  • North America
  • Market Size

TUBERCULOSIS ##. ##. ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Vaccine
  • APAC
  • Market Size

TUBERCULOSIS ##. ##. ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Vaccine
  • Europe
  • Market Size

Tuberculosis vaccine uses genetically modified vaccine comprising a recombinant MVA virus and fowl pox virus, each coding for tuberculosis antigen.

  • Gene Therapy
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Genzyme Corporation
  • Intrexon Corporation

As gene therapies are generally meant for one time or short duration treatments, they are customized to individuals confined to small patient populations.

  • Biopharmaceutical
  • Gene Therapy
  • Medical Biotechnology
  • Pharmaceutical
  • World
  • 4) Cancer Gene Therapy in the 8MM: History and Current Landscape

It is the same bug that causes tuberculosis.

  • Cancer
  • Gene Therapy
  • Medical Biotechnology
  • Therapy
  • United States
  • Chimerix Raises USD122 Million in Public Offering of Shares

It also develops active compounds against malaria, influenza A and B, brincidofovir for smallpox, dengue virus and tuberculosis, brincidofovir and adenovirus, among others.

  • Gene Therapy
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Chimerix, Inc.

As of May 2015, the drug candidate was in the discovery stage of development for the treatment of Mycobacterium tuberculosis infections.

  • Gene Therapy
  • Pharmaceutical
  • Type 2 Diabetes
  • Wound Care
  • ProMetic Life Sciences Inc.
  • VIRAL VECTOR MANUFACTURING MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • VIRAL VECTOR MANUFACTURING MARKET FOR VACCINOLOGY, BY REGION, 2016-2023 (USD MILLION)

The infection has affected children greatly, with ## million ill with tuberculosis and ##, ## children dead in 2016.

  • Gene Therapy
  • Pharmaceutical
  • North America
  • United States
  • Market Size

Tuberculosis.

  • Gene Therapy
  • Medical Biotechnology
  • Italy
  • Demand
  • Forecast

Tuberculosis.

  • Gene Therapy
  • Medical Biotechnology
  • Germany
  • Demand
  • Forecast

Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer' s disease, tumor and Parkinson' s disease, among others.

  • Gene Therapy
  • Therapy
  • United States
  • Company
  • Galapagos NV

Sutezolid is a Phase II oxazolidinone antibiotic currently in development for the treatment of tuberculosis (TB).

  • Gene Therapy
  • Medical Biotechnology
  • Therapy
  • United States
  • Pfizer Inc.

In May 2013, Kamada Ltd. announced that the Australian Patent Registrar has granted the Company a patent titled as " alpha ## antitrypsin for treating exacerbation episodes of pulmonary diseases" for the use of inhaled alpha-## antitrypsin for treating exacerbation episodes

  • Gene Therapy
  • Therapy
  • United States
  • Product Initiative
  • Kamada Ltd.
  • RETINITIS PIGMENTOSA (RETINITIS) - PIPELINE BY ID PHARMA CO LTD, H2 2017

Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer' s disease, tumor, and Parkinson' s disease.

  • Eye Disease
  • Gene Therapy
  • Pharmaceutical
  • Therapy
  • Amarantus BioScience Holdings, Inc.

Patients will be randomized ##:##:## to one of three arms: CABOMETYX and Opdivo; CABOMETYX, Opdivo and Yervoy; or sunitinib.

  • Gene Therapy
  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • Bristol-Myers Squibb Company

PHASE II DATA AND ORPHAN DRUG DESIGNATION FROM FDA AND EMA FOR NON TUBERCULOSIS MYCOBACTERIUM IS EXPECTED IN ##H 2017.

  • Gene Therapy
  • Therapy
  • United States
  • Company
  • Galapagos NV

Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer' s disease, tumor and Parkinson' s disease, among others.

  • Blood Disease
  • Gene Therapy
  • United States
  • World
  • Product Initiative

## ## Total ## ## Products in Phase II/ III and I/ II are reflected under Phase III and Phase II, respectively Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DIABETIC NEUROPATHY, H## 2018 Stage of Development Company Universities/ Institutes NUMBER OF PRODUCT

  • Gene Therapy
  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • HEMOSTEMIX INC

Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer' s disease, tumor and Parkinson' s disease, among others.

  • Angina
  • Cardiology
  • Gene Therapy
  • United States
  • Product Initiative
  • RETINITIS PIGMENTOSA (RETINITIS) - PIPELINE BY ID PHARMA CO LTD, H1 2018

Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer' s disease, tumor and Parkinson' s disease, among others.

  • Gene Therapy
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

It offers project pipeline such as products with therapeutic application in the area of diabetes type II, leishmaniasis and tuberculosis.

  • Digestive System Disorder
  • Gene Therapy
  • United States
  • World
  • Product Initiative

The vaccine is composed of lentiviral vector incorporating the extracellular domain of soluble programmed death-## (PD-##), and PD- L##.

  • Cell Therapy
  • Gene Therapy
  • Immunotherapy
  • Vaccine
  • TheraVectys

It undertakes extensive research and development of pharmaceuticals for treatment of migraine, gastrointestinal, psoriasis, central nervous system, cardiovascular, tuberculosis, diabetes and inflammation.

  • Gene Therapy
  • Ophthalmology
  • Therapy
  • Type 2 Diabetes
  • Product Initiative
  • RETINITIS PIGMENTOSA (RETINITIS) - PIPELINE BY ID PHARMA CO LTD

Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer' s disease, tumor, and Parkinson' s disease.

  • Eye Disease
  • Gene Therapy
  • Ophthalmology
  • Therapy
  • Product Initiative

In the VB-## efficacy testing in vitro showed that Arthritis induction was performed by a single intracutaneous injection of ##. ##ml emulsion (##mg/ ml Mycobacterium tuberculosis in IFA) into the base of the base of the tail on day ##.

  • Cell Therapy
  • Gene Therapy
  • Pharmaceutical
  • Therapy
  • Galectin Therapeutics Inc.